iiinova — where your digital self keeps evolving

Jie Yang @jieyang437.bsky.social · 04/08/2025

One week left to apply for the postdoc position in my lab at Oxford @ox.ac.uk Join our exciting cancer immunology research at @oncology.ox.ac.uk, @oxfordcancer.bsky.social & @oxcio.bsky.social. Deadline: 11 August 2025 (noon).

025

Jie Yang @jieyang437.bsky.social · 18/07/2025

We're recruiting a postdoc to join my lab at @oncology.ox.ac.uk & @oxcio.bsky.social to understand immune regulation in cancer and develop new approaches for cancer prevention and metastasis. Deadline: 11 August 2025 my.corehr.com/pls/uoxrecru... Lab info: www.oncology.ox.ac.uk/team/jie-yang

my.corehr.com

Job Details

059

Reposted by Jie Yang

Roychoudhuri Lab @roychoudhurilab.bsky.social · 25/03/2025

New results from the ALASCCA prospective randomised controlled trial showing daily #aspirin reduces colorectal cancer recurrence by ~50% in patients with PIK3CA or related mutations. Findings extend benefits of aspirin beyond Lynch syndrome cancers to nearly 40% of CRCs ascopubs.org/doi/10.1200/...

ascopubs.org

Low-dose aspirin to reduce recurrence rate in colorectal cancer patients with PI3K pathway alterations: 3-year results from a randomized placebo-controlled trial.

LBA125Background: Colorectal cancer (CRC) affects 1.9 million individuals globally each year. Among patients with stage II-III CRC, 20-40% develop metastatic disease. Aspirin lowers the incidence of a...

051

Reposted by Jie Yang

Roychoudhuri Lab @roychoudhurilab.bsky.social · 25/03/2025

Research Highlight of our recent paper by @jieyang437.bsky.social on Aspirin and cancer metastasis in Nature Reviews Immunology. Thanks to Yvonne Bordon for a crystal clear account of the experimental findings www.nature.com/articles/s41...

nature.com

Aspirin helps T cells to stop cancer spread - Nature Reviews Immunology

Drugs like aspirin can enhance the anti-metastatic activity of T cells by blocking a platelet-mediated pathway of suppression.

0185